NVS | Novartis A G

CUSIP: 66987V109

3 Funds Holding
86K Total Shares
$13M Total Value
$154.65
Price
$293.9B
Market Cap
23.4
P/E Ratio
15.8
Forward P/E
$6.62
EPS (TTM)
3.01%
Dividend Yield
$7.6B
Cash
$35.4B
Total Debt
1.90B
Shares Out
$121.57
$170.46
52-Week Range

Institutional Ownership of Novartis A G

Fund / Manager Click to search
Shares Value % of Portfolio Cost Basis Est. Return
Tweedy Browne Co.|Thomas Shrager
71.1K $11M
0.84%
$78.22 +99.86%
Kahn Brothers Group|Thomas Kahn
13.2K $2M
0.33%
1.5K $235168
0.00%

Trading Activity for Novartis A G

Fund / Manager Click to search
Action Change Shares After Value Price
2026-Q2
SELL -0.2% 71.1K $11M $149.77
SELL -1.5% 13.2K $2M $149.77
BUY +0.9% 1.5K $235168 $149.77
2026-Q1
SELL -6.2% 71.3K $11M $151.63
SELL -2.1% 13.4K $2M $151.63
SELL -23.1% 1.5K $227167 $151.63
2025-Q4
SELL -4.5% 13.7K $2M $131.19
SELL -5.8% 1.9K $266788 $131.19
2025-Q3
SELL -1.6% 76.1K $10M $122.78
SELL -22.4% 14.3K $2M $122.78
SELL -1.4% 2.1K $263395 $122.78
2025-Q2
SELL -4.6% 77.3K $9M $112.28
SELL -15.7% 18.5K $2M $112.28
SELL -50.8% 2.1K $252196 $112.28
2025-Q1
SELL -2.5% 81.0K $9M $107.31
BUY +3.4% 21.9K $2M $107.31
SELL -27.8% 4.2K $472236 $107.31
2024-Q4
SELL -2.6% 83.1K $8M $104.92
BUY +20.5% 21.2K $2M $104.92
SELL -20.5% 5.9K $570837 $104.92
2024-Q3
SELL -96.3% 7.4K $849075 $113.31
SELL -2.6% 85.3K $10M $113.31
2024-Q2
SELL -15.5% 202.3K $22M $100.53
SELL -2.1% 87.6K $9M $100.53
BUY +14.1% 17.6K $2M $100.53
2024-Q1
BUY +14.5% 239.5K $23M $102.64
SELL -1.3% 89.4K $9M $102.64
SELL -14.7% 15.4K $1M $102.64
2023-Q4
BUY +11.8% 209.1K $21M $96.97
SELL -4.5% 90.6K $9M $96.97
SELL -16.3% 18.1K $2M $96.97
2023-Q3
SELL -17.1% 187.0K $19M $102.04
SELL -1.2% 94.9K $10M $102.04
2023-Q2
SELL -8.2% 225.5K $23M $100.25
SELL -1.8% 96.1K $10M $100.25
2023-Q1
BUY +10.3% 245.7K $23M $86.76
SELL -1.1% 97.8K $9M $86.76
2022-Q4
SELL -17.7% 222.8K $20M $83.83
SELL -1.8% 98.9K $9M $83.83
SELL -6.5% 21.6K $2M $83.83
2022-Q3
SELL -13.3% 270.8K $21M $83.94
BUY +2.3% 100.7K $8M $83.94
2022-Q2
SELL -20.3% 312.3K $26M $88.17
SELL -3.4% 98.4K $8M $88.17
BUY +3.1% 23.1K $2M $88.17
2022-Q1
BUY +2.6% 391.8K $34M $86.64
SELL -3.9% 101.9K $9M $86.64
2021-Q4
SELL -4.8% 382.0K $33M $82.60
SELL -4.6% 106.1K $9M $82.60
BUY +9.7% 22.4K $2M $82.60
2021-Q3
SELL -6.1% 401.1K $33M $91.65
SELL -3.7% 111.2K $9M $91.65
2021-Q2
BUY +7.5% 427.0K $39M $88.25
SELL -9.6% 115.4K $11M $88.25
2021-Q1
BUY +30.0% 397.4K $34M $89.50
SELL -1.6% 127.7K $11M $89.50
SELL -8.9% 20.4K $2M $89.50
2020-Q4
SELL -3.0% 305.6K $29M $87.43
SELL -7.3% 129.8K $12M $87.43
SELL -1.3% 22.4K $2M $87.43
2020-Q3
SELL -3.4% 315.0K $27M $87.00
SELL -2.8% 140.0K $12M $87.00
2020-Q2
SELL -0.2% 326.2K $28M $85.70
SELL -4.9% 144.1K $13M $85.70
SELL -2.2% 22.7K $2M $85.70
2020-Q1
BUY +11.2% 326.7K $27M $94.25
SELL -1.4% 151.6K $12M $94.25
SELL -10.0% 23.2K $2M $94.25
2019-Q4
BUY +14.0% 293.9K $28M $89.51
SELL -0.9% 153.8K $15M $89.51
2019-Q3
SELL -7.0% 257.9K $22M $89.53
SELL -2.6% 155.1K $13M $89.53
2019-Q2
SELL -1.9% 277.3K $25M $84.22
SELL -2.5% 159.3K $15M $84.22
BUY +13.3% 25.8K $2M $84.22
2019-Q1
SELL -3.4% 282.7K $27M $79.77
SELL -5.0% 163.4K $16M $79.77
2018-Q4
SELL -35.0% 292.8K $25M $78.09
BUY NEW 172.0K $15M $78.09
SELL -2.0% 22.7K $2M $78.09
2018-Q3
SELL -2.6% 450.1K $39M $74.67
SELL EXIT $74.67
2018-Q2
BUY +12.4% 462.0K $35M $68.72
SELL -1.4% 184.9K $14M $68.72
BUY +5.5% 23.2K $2M $68.72
2018-Q1
BUY +21.7% 411.1K $33M $76.07
SELL -0.6% 187.6K $15M $76.07
SELL -17.3% 22.0K $2M $76.07
SELL EXIT $76.07

Insider Trading for Novartis A G

No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.